Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

<p>Abstract</p> <p>Background</p> <p>Tumor vasculature frequently fails to supply sufficient levels of oxygen to tumor tissue resulting in radioresistant hypoxic tumors. To improve therapeutic outcome radiotherapy (RT) may be combined with cytotoxic agents.</p> &l...

Full description

Bibliographic Details
Main Authors: Røe Kathrine, Hagtvet Eirik, Olsen Dag R
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Radiation Oncology
Online Access:http://www.ro-journal.com/content/6/1/135

Similar Items

Similar Items